Clinical Edge Journal Scan

Secondary primary malignancies are common in HCC


 

Key clinical point : Risk factors for secondary primary malignancies in HCC patients included older age at diagnosis, localized disease, smaller tumor size, and treatment with local tumor destruction, hepatectomy, and transplantation.

Major finding : A total of 1,593 HCC patients (3.95%) developed secondary primary malignancies starting at 2 months after their initial HCC diagnoses; the top five sites were lung and bronchus; prostate, non-hodgkin lymphoma, colon, and breast.

Study details : The data come from a retrospective study of 40,314 adults with hepatocellular carcinoma who were diagnosed between 2000 and 2014 and identified through the SEER database who were followed for a median of 19 months from their initial HCC diagnoses.

Disclosures: The study was supported by the National Natural Science Foundation of China. The researchers had no financial conflicts to disclose.

Source: Kong J et al. Front Oncol. 2021 Aug 23. doi: 10.3389/fonc.2021.713637.

Recommended Reading

Bone resorption inhibitors extend OS in castration-resistant prostate cancer
Federal Practitioner
Clinical Edge Journal Scan Commentary: HCC September 2021
Federal Practitioner
Antiviral Therapy Improves Hepatocellular Cancer Survival
Federal Practitioner
Adding pembrolizumab shows promise for treating unresectable HCC
Federal Practitioner
New predictive markers for risk of HCC in cirrhotic chronic hepatitis B
Federal Practitioner
Combination arsenic emulsion in TACE and apatinib benefits advanced HCC patients
Federal Practitioner
Adverse events create substantial healthcare costs in hepatocellular carcinoma
Federal Practitioner
Hepatic resection shows superior survival for resectable caudate HCC
Federal Practitioner
Higher postoperative CONUT scores predict poor outcomes in small HCC after liver resection
Federal Practitioner
Addition of raltitrixed extended overall survival in hepatocellular carcinoma
Federal Practitioner